{"id":577835,"date":"2021-12-03T17:00:01","date_gmt":"2021-12-03T17:00:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=577835"},"modified":"2021-12-03T17:00:01","modified_gmt":"2021-12-03T17:00:01","slug":"the-dynamics-of-the-degenerative-disc-disease-market-is-anticipated-to-change-in-the-coming-years-owing-to-the-improvement-in-the-rise-in-healthcare-spending-across-the-world","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/the-dynamics-of-the-degenerative-disc-disease-market-is-anticipated-to-change-in-the-coming-years-owing-to-the-improvement-in-the-rise-in-healthcare-spending-across-the-world_577835.html","title":{"rendered":"The dynamics of the Degenerative Disc Disease market is anticipated to change in the coming years owing to the improvement in the rise in healthcare spending across the world"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1638531034.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"The dynamics of the Degenerative Disc Disease market is anticipated to change in the coming years owing to the improvement in the rise in healthcare spending across the world\" src=\"https:\/\/www.abnewswire.com\/uploads\/1638531034.png\" alt=\"The dynamics of the Degenerative Disc Disease market is anticipated to change in the coming years owing to the improvement in the rise in healthcare spending across the world\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Degenerative Disc Disease Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The anticipated entry of novel therapies such as IDCT, Rexlemestrocel, and others will fuel the Degenerative Disc Disease market growth.<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/bf4dbb3b48f081a11e6d5192cc183d51.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight&rsquo;s <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/degenerative-disc-disease-ddd-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Degenerative Disc Disease market report<\/a><\/strong> thoroughly explains the Degenerative Disc Disease historical and forecasted epidemiology and the Degenerative Disc Disease market trends in the 7MM.&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some of the Key Highlights from the Degenerative Disc Disease Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">According to Bruin et al. (2018), degenerative changes were discovered in <strong>456\/648 patients (70.4%).<\/strong><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">According to data published on the International Society for Pediatric Neurosurgery (ISPN), DDD is more common than previously thought, with <strong>26%<\/strong> of asymptomatic children 16 years old demonstrating disc degeneration on MRI.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">The leading players in the Degenerative Disc Disease market include<strong> Mesoblast, Gruenthal, Stayble Therapeutics, DiscGenics, Kuros Biosciences, Ankasa Therapeutics, Biorestorative Therapies, AnGes,<\/strong> and others.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Key Degenerative Disc Disease therapies in the pipeline include <strong>Rexlemestrocel, STA363, IDCT, Fibrin-PTH (KUR-113), ART352-L, BRTX-100, AMG0103,<\/strong> and others.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Rexlemestrocel<\/strong>, also known as <strong>Rexlemestrocel-L or MPC-06-ID<\/strong>, is a lead product candidate in late-stage development by Mesoblast in collaboration with Gruenthal to treat chronic low back pain caused by disc degeneration (CLBP).<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Fibrin-PTH (KUR-113)<\/strong> is Kuros Biosciences&#8217; first investigational drug-biologic product candidate for spinal fusion.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">Request for a sample to know more @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/degenerative-disc-disease-ddd-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Degenerative Disc Disease Market Outlook<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Degenerative Disc Disease: Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Degenerative Disc Disease is a common disorder characterised by progressive degeneration of the intervertebral discs, which causes them to become deformed and mechanically dysfunctional. It is a catch-all term for various structural changes in the spine, including disc height loss, disc bulges, hydration, and nerve impingement in the spine, among others.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Degenerative Disc Disease Epidemiology Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The Degenerative Disc Disease report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Chronic Low Back Pain Total Prevalent Cases<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Degenerative Disc Disease Total Prevalent Cases<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Degenerative Disc Disease Diagnosed Cases<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Degenerative Disc Disease Age-Specific and Gender-Specific Cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Degenerative Disc Disease Severity-Specific Cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Degenerative Disc Disease Treated Cases<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Degenerative Disc Disease Treatment Landscape<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Degenerative Disc Disease treatments are either passive or active. To help control the DDD symptoms, a combination of treatments is usually used. Passive Degenerative Disc Disease treatments are rarely effective on their own; almost always, an active component, such as exercise, is required. Passive Degenerative Disc Disease treatments for low back pain caused by degenerative disc disease may include pain medication, epidural injections, artificial disc replacement, diskectomy, and spinal fusion.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Degenerative Disc Disease Market Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The anticipated entry of novel therapies such as IDCT, Rexlemestrocel, and others will fuel the Degenerative Disc Disease market growth during the forecast period (2021-30), and advances in cell biology will also contribute to the development of novel therapeutics for Degenerative Disc Disease.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Get a detailed analysis of the market @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/degenerative-disc-disease-ddd-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Degenerative Disc Disease Market Share<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Degenerative Disc Disease Pipeline Therapies and Key Companies<\/strong>&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Rexlemestrocel: Mesoblast\/ Gruenthal<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">STA363: Stayble Therapeutics<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">IDCT: DiscGenics<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Fibrin-PTH (KUR-113): Kuros Biosciences<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">ART352-L: Ankasa Therapeutics<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">BRTX-100: Biorestorative Therapies<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">AMG0103: AnGes<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents<\/strong>&nbsp;<\/p>\n<div style=\"text-align: justify;\" dir=\"ltr\" align=\"left\">\n<table>\n<colgroup>\n<col width=\"78\" \/>\n<col width=\"546\" \/><\/colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\">1.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Key Insights<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">2.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Executive Summary of Degenerative Disk Disease (DDD)<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">3.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">SWOT Analysis of Degenerative Disk Disease (DDD)<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">4.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease (DDD): Market Share (%) Distribution Overview at a Glance: By Country<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">5.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Epidemiology and Market Methodology<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">6.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease (DDD): Disease Background and Overview<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">7.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Epidemiology and Patient Population<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">8.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Epidemiology Scenario: 7MM<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">9.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease The United States Epidemiology<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">10.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease EU-5 Epidemiology<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">11.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Japan Epidemiology<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">12.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Current Treatment Practices<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">13.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Unmet Needs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">14.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Patient Journey of Degenerative Disk Disease (DDD)<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">15.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Key Endpoints in Degenerative Disk Disease (DDD) Clinical Trials<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">16.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Marketed Therapies<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">17.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Emerging Therapies<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">18.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Conjoint Analysis of Degenerative Disk Disease (DDD)<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">19.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease (DDD): Eight Major Market Analysis<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">20.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease 7MM Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">21.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease The United States Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">22.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease EU-5 Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">23.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Japan Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">24.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Market Access and Reimbursement of Degenerative Disk Disease (DDD) Therapies<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">25.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Market Drivers<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">26.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Degenerative Disk Disease Market Barriers<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">27.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Appendix<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">28.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">DelveInsight Capabilities<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">29.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Disclaimer<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">30.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">About DelveInsight<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\">Get in touch with our business executive for <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Healthcare Due Diligence Services<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/lumbar-disc-disease-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Lumbar Disc Disease Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight&#8217;s &#8220;Lumbar Disc Disease- Market Insights, Epidemiology, and Market Forecast-2030&#8221; report delivers an in-depth understanding of the Lumbar Disc Disease, historical and forecasted epidemiology as well as the Lumbar Disc Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Sandeep Joshi<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=the-dynamics-of-the-degenerative-disc-disease-market-is-anticipated-to-change-in-the-coming-years-owing-to-the-improvement-in-the-rise-in-healthcare-spending-across-the-world\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=the-dynamics-of-the-degenerative-disc-disease-market-is-anticipated-to-change-in-the-coming-years-owing-to-the-improvement-in-the-rise-in-healthcare-spending-across-the-world\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Degenerative Disc Disease Market The anticipated entry of novel therapies such as IDCT, Rexlemestrocel, and others will fuel the Degenerative Disc Disease market growth. DelveInsight&rsquo;s Degenerative Disc Disease market report thoroughly explains the Degenerative Disc Disease historical and forecasted epidemiology &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/the-dynamics-of-the-degenerative-disc-disease-market-is-anticipated-to-change-in-the-coming-years-owing-to-the-improvement-in-the-rise-in-healthcare-spending-across-the-world_577835.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,403,404],"tags":[],"class_list":["post-577835","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/577835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=577835"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/577835\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=577835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=577835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=577835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}